1h Free Analyst Time
The Targeted Sequencing Market grew from USD 6.23 billion in 2023 to USD 7.60 billion in 2024. It is expected to continue growing at a CAGR of 20.30%, reaching USD 22.73 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Targeted sequencing, a pivotal component of genomics, involves sequencing specific areas of the genome, offering a cost-effective and efficient solution compared to whole genome sequencing. Its necessity arises from the focused approach to address specific research questions, identify genetic variants related to diseases, and enhance personalized medicine applications. The technology is extensively applied in clinical diagnostics, agriculture biotechnology, and pharmaceutical development, with end-use sectors spanning from hospitals and research institutions to biotech firms and academic laboratories. Growth is influenced by advancements in sequencing technology, a surge in chronic diseases necessitating personalized therapies, and increasing investments in genomics research. The rise of precision medicine and a growing focus on rare disease identification present robust opportunities, demanding businesses to leverage partnerships and invest in R&D for innovative products.
However, challenges such as ethical concerns around genetic data handling, high costs of related technologies, and regulatory hurdles pose significant limitations. Moreover, the reliance on skilled professionals for data interpretation highlights gaps in workforce development. Addressing these challenges involves prioritizing data privacy measures, cost-effective technology innovations, and training programs in genomics. The market reveals potential in technology innovation, particularly integrating artificial intelligence and machine learning for data analysis that enhances accuracy and reduces operational costs. Additionally, innovations in sequencing methods to minimize errors and speed up processes hold promise for market players.
Business growth can be accelerated by focusing on collaborative research efforts, especially in emerging markets where genomics infrastructure is developing. Companies should anticipate regulatory changes and align their strategies to comply, ensuring long-term market sustainability. The targeted sequencing market is dynamic, with a strong growth trajectory, yet requires strategic navigation through its complexities. Engaging in continuous market analysis and investing in breakthrough technologies will enable firms to capitalize on the growing demand for precision medicine and genomics-based solutions.
Understanding Market Dynamics in the Targeted Sequencing Market
The Targeted Sequencing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.- Market Drivers
- Extensive adoption of targeted sequencing technologies in clinical diagnostics due to rapid result time and higher accuracy
- Emerging adoption in the agriculture sector to analyze the genetic potential of plants
- Increased application of targeted sequencing for precision medicines
- Market Restraints
- Lack of the computational resources and staffing to analyze and interpret clinical data
- Market Opportunities
- Continuous focus on new technology development novel targeted sequencing technologies
- Increased support from government and private sector for large scale sequencing technology
- Market Challenges
- Ethical and privacy concerns related to targeted sequencing data protection
Exploring Porter’s Five Forces for the Targeted Sequencing Market
Porter’s Five Forces framework further strengthens the insights of the Targeted Sequencing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.Applying PESTLE Analysis to the Targeted Sequencing Market
External macro-environmental factors deeply influence the performance of the Targeted Sequencing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.Analyzing Market Share in the Targeted Sequencing Market
The Targeted Sequencing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.Evaluating Vendor Success with the FPNV Positioning Matrix in the Targeted Sequencing Market
The Targeted Sequencing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.Strategic Recommendations for Success in the Targeted Sequencing Market
The Targeted Sequencing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.Key Company Profiles
The report delves into recent significant developments in the Targeted Sequencing Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., A-Alpha Bio, Inc., Agilent Technologies, Inc., Azenta Life Sciences, BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., CD Genomics, DH Life Sciences, LLC, Element Biosciences, F. Hoffmann-La Roche Ltd., Illumina, Inc., LGC Limited, Macrogen, Inc., MGI Tech Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Paragon Genomics, Inc., PerkinElmer, Inc., Psomagen, Inc., QIAGEN N.V., Singular Genomics Systems, Inc., Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.Market Segmentation & Coverage
This research report categorizes the Targeted Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product Type
- Consumables
- Platforms
- Services
- Application
- Cardiovascular Diseases
- Hereditary Diseases
- Infectious Diseases
- Neurological Disorders
- Oncology
- Reproductive Health
- End-User
- Academic & Research Institutes
- Clinical Laboratories
- Contract Research Organization
- Pharmaceutical & Biotechnology Companies
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report provides a detailed overview of the market, exploring several key areas:
- Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
- Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
- Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
- Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
- Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.
Additionally, the report addresses key questions to assist stakeholders in making informed decisions:
- What is the current size of the market, and how is it expected to grow?
- Which products, segments, and regions present the most attractive investment opportunities?
- What are the prevailing technology trends and regulatory factors influencing the market?
- How do top vendors rank regarding market share and competitive positioning?
- What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Targeted Sequencing Market, by Product Type
7. Targeted Sequencing Market, by Application
8. Targeted Sequencing Market, by End-User
9. Americas Targeted Sequencing Market
10. Asia-Pacific Targeted Sequencing Market
11. Europe, Middle East & Africa Targeted Sequencing Market
12. Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
The leading players in the Targeted Sequencing Market, which are profiled in this report, include:- 10x Genomics, Inc.
- A-Alpha Bio, Inc.
- Agilent Technologies, Inc.
- Azenta Life Sciences
- BGI Genomics Co., Ltd.
- Bio-Rad Laboratories, Inc.
- CD Genomics
- DH Life Sciences, LLC
- Element Biosciences
- F. Hoffmann-La Roche Ltd.
- Illumina, Inc.
- LGC Limited
- Macrogen, Inc.
- MGI Tech Co., Ltd.
- Oxford Nanopore Technologies PLC
- Pacific Biosciences of California, Inc.
- Paragon Genomics, Inc.
- PerkinElmer, Inc.
- Psomagen, Inc.
- QIAGEN N.V.
- Singular Genomics Systems, Inc.
- Takara Bio Inc.
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
- Twist Bioscience Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 190 |
| Published | October 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 7.6 Billion |
| Forecasted Market Value ( USD | $ 22.73 Billion |
| Compound Annual Growth Rate | 20.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
